[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371918-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371918-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","activated-protein-c-promotes-human-lung-cancer-progression-through-the-release-of-tumor-extracellular-vesicles-and-transfer-of-microrna-200a-research-article","Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a - research article","","Blood coagulation and cancer are closely linked through hypercoagulation, which increases aberrant thrombin generation and thrombosis in malignancies such as lung cancer. Activated protein C (aPC), beyond anticoagulant regulation via EPCR and PAR1, promotes lung adenocarcinoma survival and metastasis, yet the mechanism has been unclear. This study shows aPC triggers extracellular vesicle release via EPCR-PAR1-driven RhoA-ROCKII-JNK1/2-MLC2 signaling. aPC-derived extracellular vesicles transfer microRNA-200a to enhance proliferation, migration, invasion, and chemotherapy resistance, with anti-miR-200a or miR-200a mimic experiments implicating miR-200a targeting SOX17 and driving tumorigenic outcomes in vitro and in BALB/c nude mice.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/activated-protein-c-promotes-human-lung-cancer-progression-through-the-release-of-tumor-extracellular-vesicles-and-transfer-of-microrna-200a-research-article/371918/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/activated-protein-c-promotes-human-lung-cancer-progression-through-the-release-of-tumor-extracellular-vesicles-and-transfer-of-microrna-200a-research-article/371918.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological link does the study describe between coagulation and lung cancer progression?","Question",{"text":63,"@type":64},"It describes how hypercoagulation in cancer promotes aberrant thrombin generation and thrombosis, while thrombin-derived signaling activates protein C to generate activated protein C (aPC). aPC then engages EPCR and PAR1 signaling and influences lung adenocarcinoma behavior.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does activated protein C promote lung adenocarcinoma progression according to the study?",{"text":68,"@type":64},"Activated protein C activates EPCR–PAR1-driven RhoA-ROCKII-JNK1/2-MLC2 signaling, which triggers extracellular vesicle (EV) release from lung adenocarcinoma cells. These EVs then promote proliferation, migration, invasion, and drug resistance in recipient cells.",{"name":70,"@type":61,"acceptedAnswer":71},"Which microRNA is identified as a key mediator, and what target does it affect?",{"text":72,"@type":64},"The study identifies microRNA-200a (miR-200a) transferred via aPC-EVs as a key mediator. miR-200a targets SOX17 in recipient cells, leading to tumorigenic effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371918,1790769882,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nActivated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a  \nMadhura Chatterjee1,2, Deepak Parashar3, Rajan Pandey4,5, Tanmoy Mukherjee6, Saurabh Gupta7, Subhojit Paul8, Akash Chatterjee8, Gunjan Potale 1, Prity Dhara 1, V. V. Sathibabu Uddandrao 9,10, S. Sengottuvelu11, Aishwarya Sharma 12, Umesh Kumar 13, Jhansi Magisetty 14, Arindam Maitra 1 ✉ and Kaushik Das 1 ✉  \n© The Author(s) 2025  \n\n| | Blood coagulation and cancer are intricately related. Hypercoagulation associated with cancer leads to aberrant thrombin generation, which contributes to thrombosis. Thrombin also activates anticoagulant protein C and the activated protein C (aPC), in addition to regulating the coagulation pathway, it also elicits cell signaling by binding to endothelial cell protein C receptor (EPCR) and activating protease-activated receptor 1 (PAR1)-mediated cell signaling. Earlier studies showed that aPC promotes lung adenocarcinoma survival and metastasis. However, the underlying mechanism remains largely unknown. Our present study provides mechanistic insight into how aPC promotes lung adenocarcinoma survival, metastasis, and drug resistance. Our study shows that aPC, through EPCR-PAR1-driven activation of RhoA-ROCKII-JNK1/2-MLC2 signaling, triggers extracellular vesicle (EV) release from lung adenocarcinoma cells. aPC-EVs, via the transfer of microRNA (miR)-200a, promote proliferation, migration, and invasion of normal lung epithelial cells. They also confer resistance to lung cancer against chemotherapeutic agents. Inhibition of miR-200a functions through the incorporation of anti-miR-200a abrogates aPC-EVs-mediated tumorigenic effects. Furthermore, loading miR-200a mimic into control EVs showed similar phenotypic responses to that of aPC-EVs. miR-200a is shown to target SOX17 in the recipient cells, leading to tumorigenesis. miR-200a upregulation and SOX17 downregulation are consistently observed in lung cancer tissues in the UALCAN portal database of clinical specimens. Consistent with these ﬁndings, our in vivo studies in BALB/c nude mice showed that aPC-EVs from lung cancer cells promote tumor growth, metastasis, and drug resistance through miR-200a transfer. Targeting EV biogenesis, EV’s miR-200a, and/or EV uptake mechanisms may offer novel therapeutic strategies in | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | limiting lung tumorigenesis, thereby increasing patients’ survival. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2025)16:848; [https://doi.org/10.1038/s41419-025-08173-z](https://doi.org/10.1038/s41419-025-08173-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nBlood coagulation and cancer are intrinsically connected [1, 2]; hypercoagulation-associated thrombotic complications such as venous thromboembolism (VTE) are commonly observed in certain cancer types such as lung cancer [3], accounting for increased morbidity and mortality of patients. The risk of VTE in lung cancer increases with cancer progression [4–6], in ﬁrst line of treatment it varies from 5 to 13% [7–9]. Although hypercoagulation is wellestablished in lung cancer pathogenesis [3], how coagulation proteases inﬂuence lung cancer progression remains largely  \nunknown. Thrombin is used as an emerging biomarker, assessing global activation of coagulation and increased risk of VTE in lung cancer patients [10]. Binding of thrombin with thrombomodulin triggers the activation of endothelial cell protein C receptor (EPCR)-bound protein C to generate activated protein C (aPC) [11]. aPC, in presence of co-factors [12], cleaves and inactivates activated factor V (FVa) and-VIII (FVIIIa) [13, 14], thereby serving as an anti-coagulant to restore homeostasis. Other than anti-coagulant functions, aPC-","cbCaitQ4JGzit39Q","https://ap.wps.com/l/cbCaitQ4JGzit39Q","pdf",6071726,16,"English","# Introduction\n## Blood coagulation, hypercoagulation, and VTE in lung cancer\n## Thrombin–thrombomodulin–EPCR–protein C axis and activated protein C functions\n## aPC-EPCR and PAR1-mediated cytoprotective signaling","[{\"question\":\"What biological link does the study describe between coagulation and lung cancer progression?\",\"answer\":\"It describes how hypercoagulation in cancer promotes aberrant thrombin generation and thrombosis, while thrombin-derived signaling activates protein C to generate activated protein C (aPC). aPC then engages EPCR and PAR1 signaling and influences lung adenocarcinoma behavior.\"},{\"question\":\"How does activated protein C promote lung adenocarcinoma progression according to the study?\",\"answer\":\"Activated protein C activates EPCR–PAR1-driven RhoA-ROCKII-JNK1/2-MLC2 signaling, which triggers extracellular vesicle (EV) release from lung adenocarcinoma cells. These EVs then promote proliferation, migration, invasion, and drug resistance in recipient cells.\"},{\"question\":\"Which microRNA is identified as a key mediator, and what target does it affect?\",\"answer\":\"The study identifies microRNA-200a (miR-200a) transferred via aPC-EVs as a key mediator. miR-200a targets SOX17 in recipient cells, leading to tumorigenic effects.\"}]","Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a - research article | PDF",1790193219,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e7a15368334d9752697db0dcb26777f.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4486ad3f7f8acd8fbcfb760f3d627628.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/871d8318fb602b24d512cf9536d84da5.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/825fb9494c3b036309ca0263297706a8.webp",980,1301]